SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
ESRX Analysis & Videos »
ESRX: Bull or Bear?
Express Scripts Keeps Rolling Along
ESRX
-7.11%
in
66 days
(closed on 03/14/11)
Filed under: Stocks to Buy The positive story continues with pharmacy benefits manager Express Scripts Inc. (ESRX), which I first wrote about on June 9, 2009 at a 2-for-1, split-adjusted price of $31.82.
In fact, the uptrend has been so impressive, Express traded at/near $56 on Friday, those in since June 2009 may wish to consider taking some profits off the table, to say the least. It never hurts a portfolio to take a portion of a roughly 80% gain.
Those who can tolerate the risk can maintain their full Express position and go for an even larger gain, as ESRX is likely to continue to head nor...
|
Express Scripts (ESRX): The Right Prescription?
ESRX
+14.40%
in
925 days
Filed under: Newsletters, Stocks to Buy, Obama Picks "One thing that will continue to play out -- regardless of the direction of health care policy and law -- consumers and spenders of health care dollars need to spend less," notes Neil George.
The editor of The Pay Me Strategy explains, "One solution for more efficient spending comes from Express Scripts (ESRX), which is right in the thick of the issue of prescription drugs and drug costs. The Saint Louis-based company is one of the leaders in pharmaceutical benefit management.
"To get lower drug prices -- you need to not only advance the eff...
|
Express Scripts: Well-Positioned for Earnings Growth
ESRX
+16.22%
in
92 days
(closed on 01/07/11)
Filed under: Stocks to Buy The shares of pharmacy benefits manager Express Scripts (ESRX), which I first wrote about on June 9, 2009, at a 2-for-1 split-adjusted price of $31.82, remains a play with promise.
Express's 2010 revenue will likely vault more than 80% on new accounts and the NextRx PBM purchase. Express is in a "prescription sweetspot" of sorts: an aging populace, plus a likely renewed emphasis on health and wellness in the United States, and the possibility of federal, health care reform legislation, bodes well for many health care players, and pharmacy benefits managers. <><>Continue >>...
|
Express Scripts (ESRX): Prescription for Profits
ESRX
+17.30%
in
120 days
(closed on 12/07/10)
Filed under: Newsletters, Stocks to Buy "Pharmacy benefits managers (PBMs) are the main distributors of drugs to retail pharmacies and directly to consumers; in our view, the PBM sector is a must-have health care area for investors," says Stephen Leeb.
The editor of The Complete Investor explains, "Express Scripts (ESRX) is a leading and fast-growing pure-play PBM that has been generating impressive results and is undervalued relative to the industry.
"One striking health care trend in recent years has been a dramatic rise in prescriptions. For the 10 years ended in 2009, according to a govern...
|
Express Scripts Races Ahead
ESRX
-52.47%
in
133 days
(closed on 10/07/10)
Filed under: Stocks to Buy As forecast in March, pharmacy benefits manager Express Scripts Inc. (ESRX), first discussed on June 9, 2009 at a price of $63.64, has zoomed to $100, and it may be at $110 before long. I obviously still like the shares.
How much upside remains? Considerable. Look for Express' 2010 revenue to zoom more than 70% on new accounts and the NextRx PBM purchase. An aging populace, plus a likely renewed emphasis on health and wellness in the United States, and recent federal health care reform legislation bodes well for many health care players and pharmacy benefits manage...
|
Cramer on BloggingStocks: China-led drop offers a time to buy
ESRX
-7.13%
in
1400 days
Filed under: Apple Inc (AAPL), Ford Motor (F), Exxon Mobil (XOM), China, Market matters, Citigroup Inc. (C), Target Corp. (TGT), BB and T (BBT), Bristol-Myers Squibb (BMY), Wendy's Intl (WEN), BHP Billiton Ltd ADR (BHP), Freep't McMoRan Copper (FCX), Stocks to Buy, Union Pacific Corporation (UNP), Cramer on BloggingStocks, Potash Corp. of Saskatchewan (POT) TheStreet.com's Jim Cramer says even stocks without exposure to that country will probably be on sale today.
If China has...
|
Cramer on BloggingStocks: You can't afford to be certain
ESRX
-6.83%
in
19 days
(closed on 08/19/09)
<>Filed under: Apple Inc (AAPL), Hewlett-Packard (HPQ), Ford Motor (F), Market matters, Walt Disney (DIS), International Business Machines (IBM), AT and T (T), 3M Corporation (MMM), Caterpillar (CAT), Schlumberger Limited (SLB), Citigroup Inc. (C), Johnson and Johnson (JNJ), JPMorgan Chase (JPM), Bank of America (BAC), Bed Bath and Beyond (BBBY), Best Buy (BBY), FedEx Corp (FDX), Verizon Communications (VZ), Lennar Corp'A' (LEN), United Parcel'B' (UPS), Anadarko Petroleum (APC), Wells Fargo (WFC), Stocks to Buy, Norfolk Southern Corp. (NSC), Union Pacific Corporation (UNP), <>Cramer on Blogging>>...
|
Bullish on ESRX ...
ESRX
|
|
|
+43.63%
in
1543 days
Express Scripts, Inc. offers a range of pharmacy benefit management (PBM) services in North America. The company provides retail network pharmacy management, retail drug card programs, home delivery pharmacy services, benefit design consultation, drug utilization review, drug formulary management programs, and compliance and therapy management programs. It also offers integrated PBM services that comprise network claims processing, home delivery services, benefit design consultation, drug utilization review, formulary management, and drug data analysis services. In addition, Express Scripts...
|
Health Benefit Providers Index Drops on Reform Prospects
ESRX
|
|
|
+24.18%
in
1572 days
The accompanying table includes 38 companies in the ETF Innovators Health Benefit Providers Index, which was down sharply in the past week and has lost 14% of its market value to a level of 192,305 since I last wrote about the group five weeks ago. <> <> The uncertain future for health insurers and benefit providers that I wrote about previously came to a head this week with plans by President Obama for healthcare reform aimed at cutting health costs by favoring generic drug makers and smaller Medicare Advantage payments to private insurers, along with smaller increases>>...
|
Healthcare Investing Trends in '09 and Beyond
ESRX
|
|
|
-14.29%
in
21 days
(closed on 02/28/09)
<> While the departure of Tom Daschle and concerns over rising unemployment and the global economic slowdown may hamper many of President Obama's plans for healthcare reform; there are several growth trends within the sector outlined below which are poised to benefit in 2009 and beyond. Follow any of the links below for more information on the new ETF Innovators indexes and exchange-traded fund ideas for the sector. Global Health IT : The top five rated companies include Swiss telemedicine firm Card Guard (CDGUF) – a pro< />< />< />< /><>>< />< />< />< /><>><>>< />< /><>>< />< />< />< /><>>>...
|
A New Global Healthcare Composite Index
ESRX
|
|
|
+4.42%
in
4 days
(closed on 11/27/08)
<> The accompanying table [click to enlarge or download] presents the top five rated companies with market caps of at least $250M from each of the 10 new healthcare indexes developed by ETF Innovators [ETFI] from a database of about 500 companies worldwide. The ETFI Global Healthcare Sector PerformIdex consists of 50 top rated companies on an equal weight basis from each of the 10 new healthcare indexes as an alternative strategy to existing health composite ETFs with highly correlated returns and over-weight exposure to th>...
|
People Bullish on ESRX
People Bearish on ESRX
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on ESRX |
Be the first to start a discussion and earn 2 points.
More Resources
|